Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- Check7 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0. The study record content appears unchanged.SummaryDifference0.1%

- Check14 days agoChange DetectedA notice announces NIH website updates and FAQs about using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference0.6%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1, with no change to the clinical trial record history.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history. The previous revision v3.6.6 was removed, indicating a newer system update to the history page.SummaryDifference0.1%

- Check70 days agoChange DetectedNew revision entry Revision: v3.6.6 has been added to the record history, and the previous entry Revision: v3.6.5 has been removed. This updates the history tracking to reflect the latest version of the study record.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.